MedPath

Emtricitabine and tenofovir disoproxil fumarate

Generic Name
Emtricitabine and tenofovir disoproxil fumarate
Indication

适用于与其他抗逆转录病毒药物联用,治疗成人和12岁(含)以上儿童的 HIV-1感染。

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

First Posted Date
2004-12-20
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
484
Registration Number
NCT00099632
Locations
🇮🇳

Chennai Antiviral Research and Treatment (CART) CRS, Chennai, Tamil Nadu, India

🇮🇳

Byramjee Jeejeebhoy Government Medical College CRS, Pune, Maharashtra, India

🇲🇼

Blantyre CRS, Blantyre, Malawi

and more 5 locations

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

First Posted Date
2004-08-06
Last Posted Date
2018-10-12
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Target Recruit Count
745
Registration Number
NCT00089505
Locations
🇿🇦

University of Witwatersrand, Johannesburg, South Africa

🇧🇼

The Gaborone BHP Study Clinic, Bontleng, Gaborone, Botswana

🇿🇲

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia

and more 8 locations

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

First Posted Date
2004-06-08
Last Posted Date
2018-10-10
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Target Recruit Count
1571
Registration Number
NCT00084136
Locations
🇺🇸

University of Texas, Galveston, Galveston, Texas, United States

🇲🇼

College of Med. JHU CRS, P.O. Box 1131, Blantyre, Malawi

🇿🇼

UZ-Parirenyatwa CRS, AIDS Research Unit P.O. Box A178, Harare, Zimbabwe

and more 39 locations

Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants

First Posted Date
2004-02-06
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
66
Registration Number
NCT00076791
Locations
🇺🇸

Children's Hospital of Michigan NICHD CRS, Detroit, Michigan, United States

🇺🇸

Nyu Ny Nichd Crs, New York, New York, United States

🇺🇸

Regional Med. Ctr. at Memphis, Memphis, Tennessee, United States

and more 9 locations

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

First Posted Date
2003-12-17
Last Posted Date
2021-11-05
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
3526
Registration Number
NCT00074581
Locations
🇺🇸

Fenway Community Health Ctr. CRS, Boston, Massachusetts, United States

🇧🇼

Gaborone CRS, Gaborone, Botswana

🇧🇷

Hospital Geral de Nova Iguaçu CRS (HGNI CRS), Nova Iguacu, Rio De Janeiro, Brazil

and more 14 locations

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Phase 4
Completed
Conditions
AIDS-Related Opportunistic Infections
HIV Infections
First Posted Date
2003-02-20
Last Posted Date
2014-10-15
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
283
Registration Number
NCT00055120
Locations
🇺🇸

Brigham and Womens Hospital, Boston, Massachusetts, United States

🇺🇸

University of California, Davis Medical Center, Sacramento, California, United States

🇺🇸

Santa Clara Valley Medical Center, Stanford, California, United States

and more 42 locations
© Copyright 2025. All Rights Reserved by MedPath